Nalaganje...
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
BACKGROUND: Intravitreal ranibizumab prevents vision loss and improves visual acuity in patients with neovascular age-related macular degeneration, but it is expensive, and efficacy beyond 2 years is uncertain. METHODS: We assessed the cost-effectiveness of ranibizumab compared with no ranibizumab o...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2008
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2443361/ https://ncbi.nlm.nih.gov/pubmed/18573218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1478-7547-6-12 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|